{"name":"Drug Induced Liver Disease Study Group","slug":"drug-induced-liver-disease-study-group","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5aeUc2VzdjQk5FM01uakRNdEZmcDNWVVg3U0RRU1QwX1JLZ2lBeWEtMzlEVVF2NnFDWVRoYTdLX0NQeG5fd20tSWg3dVBPZ2FkMFpXT3V5UWpyT3pLcVZN?oc=5","date":"2025-12-24","type":"pipeline","source":"nature.com","summary":"Apoptotic signatures allow early and rapid screening of drug-induced liver injury to accelerate drug discovery - nature.com","headline":"Apoptotic signatures allow early and rapid screening of drug-induced liver injury to accelerate drug discovery","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxQX2JBOGVMVDlGQWllem9hMVlrd0Q1T0Uyb3ZOZEYzTTRsSTRlLVdvcFdNZkVLam1MZzhQT3VMTVZiNWRDc2tHQ1paZUtaNm5ScWJReFJXVEVOenFGUDdIem82Rjl5NlRHajM0QTJsemVaNTN1a0tCT011ekVrM0lSTXc2Nm5wd1hBMkFuRkMxWGZxejVaNDRFNDkta0EzTDEtbkJ1WGdKWUlUc1ZOVElPQnNJQnRzcWFzeFl5aVpJMXppU1V5?oc=5","date":"2025-11-24","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"Cellarity’s AI Model Improves Drug Safety by Predicting Liver Injury - Genetic Engineering and Biotechnology News","headline":"Cellarity’s AI Model Improves Drug Safety by Predicting Liver Injury","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTFBCeW1HYURxYXlRZEhyZXFxRDRoaDFNbmNNb2E3YnctSUZRSkJ4aVhvUlVLVUZOMHNOZS1kalJCY2JkM0kwYl9LMndVZHlrZHFnQl85X19SWEZFbUZoX3I0VWVMTWljWFdnN05SWjUwanZxRFlKRGZDYnJPU3NMdw?oc=5","date":"2025-10-04","type":"pipeline","source":"The New York Times","summary":"How Private Equity Oversees the Ethics of Drug Research - The New York Times","headline":"How Private Equity Oversees the Ethics of Drug Research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxPMHhROTZMX2EwRnRIdWI2bTlxQW8wbWtxUU9NalRrRG1fclVDa1lMcVl2RzIwWjkwa3lyR2t0Q0dRbU80UkNQX2pCMU5GeGExNmxBRWlzWUZodGc4a0RILWNCQjQ2M0hFVUlkVlFzNVJKNTdYb2x6ZGN3bkhwR0Eya2wtLWdNVWxPRlRPVFhGRjJUYVE5WVNEZHVVY0pReFV5MGNvV05ESkpKSzJCS3k2X2pyN0pxZzQxNHhHMkZSSFV2eVpiazBN?oc=5","date":"2025-09-11","type":"pipeline","source":"Fierce Pharma","summary":"Intercept, after many setbacks, pulls liver disease drug Ocaliva in US - Fierce Pharma","headline":"Intercept, after many setbacks, pulls liver disease drug Ocaliva in US","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE4tYWx3UUxIazVTTnhicFRvRTlLb3hzM3dzZWQ3dGdtT19YcGhsakJNdUdGWGdMSER5Z0R5bVh6WjZTTzdYanNqTzVBbDI3OURmNzNXOTZWeEhLU3p2TEFR?oc=5","date":"2025-07-26","type":"pipeline","source":"nature.com","summary":"Aegeline improves doxorubicin-induced liver toxicity by modulating oxidative stress and Bax/Bcl2/caspase/NF-κB signaling - nature.com","headline":"Aegeline improves doxorubicin-induced liver toxicity by modulating oxidative stress and Bax/Bcl2/caspase/NF-κB signaling","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE42UF9OemtGZGR6cHNLM0xqUWRGVmNXMmVyOF9vTHFMVXpEMjRST1lCNjhTY1lvWFh3aUJzXzk1emhNWVFaUGQ0NlFTUGZrSTc4WEkxY3FsZXNTOUdpeExPbWs2dlphc0ZlTHdNSGVR?oc=5","date":"2025-06-25","type":"pipeline","source":"British Pharmacological Society | Journals","summary":"BPS Publications - British Pharmacological Society | Journals","headline":"BPS Publications - British Pharmacological Society | Journals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQN0R6aEt1MXI5ZUFoM0xyU0dGV21rNFNnWmxaV3d4WU40c1lJRFB6bE5HTFF1Y2tGUGJVMUg2WHFlcEY3RFB5N2V3RUphMGdPNVAzNDFOWTJTcjZNLXI3dlZXVmE0NGx6dTNVTDhQbGQ1Nm5ITGVDSFNMelJ1VHBlWWVHbjBoSmxvR1I0Y2pDckc?oc=5","date":"2025-06-11","type":"pipeline","source":"Frontiers","summary":"Bioengineering of novel organotypic 3D human liver tissue model for drug-induced liver injury and toxicity studies - Frontiers","headline":"Bioengineering of novel organotypic 3D human liver tissue model for drug-induced liver injury and toxicity studies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQR0U4ODhEVnR1RnlIM0ZJdzhyZDYtQ1RGOE1yMExqSkwtMVlOTVJXZ3VRT2Fjb3c0U0gyOHlaS2xyN0FNZ2NpZjR3dkRwc3VHMGxfSDAwaUhRNjJyekdLcmlYMHBFY0hQMGxRREVkOVFBMmF5bDVSOVBCb1pjbjd5bmdqUGJLUjFJNkt1OGcyV3JVS3RYd1pIZFpXZy1UaTlQSzZRa3pDOEc1Mld3WFBDbUNlT29MTWtr?oc=5","date":"2025-05-27","type":"pipeline","source":"NBC News","summary":"Drug-induced liver injuries rise in the U.S. as supplements grow in popularity: What to know - NBC News","headline":"Drug-induced liver injuries rise in the U.S. as supplements grow in popularity: What to know","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNNHdoWWI5STJwUnIzY2w2Mi1wc1JTckNRN2RFREEwaUFPS2V6akx5STB0dENMZnpRQnVPNnVhcUxJc3JNV2NJeUxLTWpWM3lWUnZxMS1XVHJGV1ZJVExMVEliZ2lxY20yMU94RHpOUC0zVHFXaElyV3FVdWNwdjFVMGpfa1R2RTdFbXA3YVVVcjhvVldXUjJCWUNhaXpXUFgw?oc=5","date":"2024-06-25","type":"pipeline","source":"Penn Medicine","summary":"New approach accurately identifies medications most toxic to the liver - Penn Medicine","headline":"New approach accurately identifies medications most toxic to the liver","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE9Vc0ZwdzZMbVlsY0ZjeU5pWTZ0Sy1LNk45RVJnLWoyS3JxZkstY2l3a1FYeVVVSzBUcnoxbHNTNDNKUmR1WWRtOENySURkNW1oaHJlLVNQdmJIWW12Ykl5bw?oc=5","date":"2024-02-07","type":"trial","source":"NEJM","summary":"A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis - NEJM","headline":"A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE1rVDRMRzF6Mndfb0dhVUFlMW1Ib1Nud0p6RTBrVmNsNFd4UjRpaTVtcWZRNmJ3eUpBdVI4Xzc4UnlTcDdSQl92Y1RmajdubldKZ3YxbWFDWlRRRmprcFNZdXl4RGNjdWVsRjBzUkc1Wl9yTm1MNzMyQUhFZw?oc=5","date":"2023-09-17","type":"regulatory","source":"medrxiv.org","summary":"Drug-induced liver injury associated with elexacaftor/tezacaftor/ivacaftor from the FDA Adverse Event Reporting System (FAERS) - medrxiv.org","headline":"Drug-induced liver injury associated with elexacaftor/tezacaftor/ivacaftor from the FDA Adverse Event Reporting System (","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNVTRCZ0E5NzJlNFA1OHFNbE5YbHZHWUZ1bV96Q3VYZVNFOGNiY3JFV0Z5TnVBaS1XS2pQUWY5dXdfT1VjWkZhZWZMMnlzNzBfQi1pZmVzMVJ4X05oZVFwWVhKN2RXM1VDMmJ6VDItcVFkV3F6dzRwdjZyUDVNX1dnZ05sYTZjckMtUUEwamxVeEhRLVdid2NQSjRkdkVXQkVRY01SUWY2a0lTZw?oc=5","date":"2022-04-01","type":"pipeline","source":"National Institutes of Health (.gov)","summary":"LiverTox: An Online Resource for Information on Drug-induced Liver Injury - National Institutes of Health (.gov)","headline":"LiverTox: An Online Resource for Information on Drug-induced Liver Injury - National Institutes of Health (.gov)","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}